Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

British Journal of Cancer
Jack CuzickTransatlantic Prostate Group

Abstract

The natural history of prostate cancer is highly variable and it is difficult to predict. We showed previously that a cell cycle progression (CCP) score was a robust predictor of outcome in a conservatively managed cohort diagnosed by transurethral resection of the prostate. A greater need is to predict outcome in patients diagnosed by needle biopsy. Total RNA was extracted from paraffin specimens. A CCP score was calculated from expression levels of 31 genes. Clinical variables consisted of centrally re-reviewed Gleason score, baseline prostate-specific antigen level, age, clinical stage, and extent of disease. The primary endpoint was death from prostate cancer. In univariate analysis (n=349), the hazard ratio (HR) for death from prostate cancer was 2.02 (95% CI (1.62, 2.53), P<10(-9)) for a one-unit increase in CCP score. The CCP score was only weakly correlated with standard prognostic factors and in a multivariate analysis, CCP score dominated (HR for one-unit increase=1.65, 95% CI (1.31, 2.09), P=3 × 10(-5)), with Gleason score (P=5 × 10(-4)) and prostate-specific antigen (PSA) (P=0.017) providing significant additional contributions. For conservatively managed patients, the CCP score is the strongest independent predicto...Continue Reading

References

Nov 15, 1977·International Journal of Cancer. Journal International Du Cancer·N BreslowH Tulinius
Oct 27, 1984·British Medical Journal·I S FentimanJ L Hayward
Jan 29, 1994·Lancet·G L Lu-Yao, E R Greenberg
Jul 4, 2002·Journal of the National Cancer Institute·Ruth EtzioniEric J Feuer
Aug 11, 2005·British Journal of Cancer·S JhavarC S Cooper
Oct 6, 2005·European Urology·Gyorgyike SoosBalazs Dezso
Nov 2, 2006·British Journal of Cancer·J CuzickUNKNOWN Transatlantic Prostate Group
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin

❮ Previous
Next ❯

Citations

May 14, 2014·Nature Reviews. Clinical Oncology·Laurence Klotz, Mark Emberton
Feb 20, 2014·TheScientificWorldJournal·Petra HudlerRadovan Komel
Jul 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Haley HieronymusCharles L Sawyers
Dec 19, 2013·PloS One·Christian R GomezStanimir Vuk-Pavlović
May 30, 2012·Nature Genetics·Haley Hieronymus, Charles L Sawyers
May 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Riggs, R T Burks
Feb 26, 2015·Expert Review of Molecular Diagnostics·Lisa MurphyR William Watson
Nov 14, 2015·Expert Review of Molecular Diagnostics·Monica SagerJimmy Lin
Dec 11, 2013·Current Medical Research and Opinion·Neal ShoreMichael K Brawer
Mar 1, 2014·Current Medical Research and Opinion·E David CrawfordMichael K Brawer
Jul 1, 2015·Prostate Cancer and Prostatic Diseases·A E RossS J Freedland
Jan 16, 2016·Future Oncology·Matteo FerroOttavio De Cobelli
Oct 31, 2015·Annual Review of Medicine·Itay A SternbergPeter T Scardino
Mar 10, 2016·Nature Reviews. Urology·Jeffrey J TosoianStacy Loeb
May 9, 2015·Future Oncology·Chiara CiccareseRodolfo Montironi
Sep 5, 2015·BioMed Research International·Jeong Hyun Kim, Sung Kyu Hong
Mar 25, 2015·Nature Reviews. Urology·Jennifer A LockeRobert G Bristow
Oct 13, 2016·Future Oncology·Hyun KimRobert B Den
Dec 6, 2016·International Neurourology Journal·Liyan Zhuang, Matthew T Johnson
Jul 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kosj YamoahEdward M Schaeffer
Mar 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R CooperbergPeter R Carroll
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald C ChenSuneil Jain
Mar 10, 2017·Expert Review of Molecular Diagnostics·Michele ColicchiaR Jeffrey Karnes
Apr 19, 2017·Cancer Biology & Therapy·Daniel K Lee, William D Figg
Mar 9, 2017·International Journal of Environmental Research and Public Health·Junli DengYuan-Shan Zhu
Apr 15, 2014·The Urologic Clinics of North America·Brian T Helfand, William J Catalona
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·Theodorus H Van der Kwast
Dec 11, 2014·Cancer·Zachary KlaassenStephen J Freedland
Mar 15, 2014·Current Opinion in Oncology·David A Sartori, Daniel W Chan
Jun 22, 2017·Expert Review of Anticancer Therapy·Kae Jack TayThomas J Polascik
Jun 22, 2017·Expert Review of Molecular Diagnostics·Minke SmitsJack A Schalken
Dec 3, 2013·Therapeutic Advances in Urology·K Clint Cary, Mathew R Cooperberg
Jul 1, 2017·Current Opinion in Urology·Stacy Loeb, Ashley E Ross

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy
PCR

Clinical Trials Mentioned

NCT00430183

Software Mentioned

STATA
Q Statistic
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Jack Cuzick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Matthew R CooperbergPeter R Carroll
© 2022 Meta ULC. All rights reserved